Funding for this research was provided by:
Medical University of South Carolina
Article History
Accepted: 31 March 2025
First Online: 24 April 2025
Declarations
:
: Open access funding provided by the Carolinas Consortium. Dr. Flume is supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health under grant no. UL1 TR001450. Dr. Sullivan receives funding from the Cystic Fibrosis Foundation. Dr. Mingora receives funding from the Cystic Fibrosis Foundation.
: Dr. Flume has grant support from Boeringher-Ingelheim, Cystic Fibrosis Foundation Therapeutics, National Institutes of Health, and Vertex Pharmaceuticals, Inc, and provides consultation to Sionna and Vertex Pharmaceuticals, Inc.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed substantially to the writing of the manuscript.